{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T20:49:33Z","timestamp":1794516573253,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-12-2-0012"],"award-info":[{"award-number":["W81XWH-12-2-0012"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13195-019-0471-6","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T16:03:53Z","timestamp":1548950633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"11","author":[{"name":"Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar A.","family":"Halawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Gatchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Amariglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorene M.","family":"Rentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reisa A.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad A.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"471_CR1","doi-asserted-by":"crossref","unstructured":"Association, A.S., 2016 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s dementia, 2016 12(4): p. 459\u2013509.","DOI":"10.1016\/j.jalz.2016.03.001"},{"issue":"3","key":"471_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jalz.2010.04.005","volume":"7","author":"GA Marshall","year":"2011","unstructured":"Marshall GA, et al. Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):300\u20138.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"471_CR3","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1037\/a0029857","volume":"27","author":"RS Wilson","year":"2012","unstructured":"Wilson RS, et al. The natural history of cognitive decline in Alzheimer\u2019s disease. Psychol Aging. 2012;27(4):1008\u201317.","journal-title":"Psychol Aging"},{"key":"471_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","volume":"37","author":"RI Pfeffer","year":"1982","unstructured":"Pfeffer RI, et al. Measurement of functional activities in older adults in the community. J Geron. 1982;37:323\u20139.","journal-title":"J Geron"},{"key":"471_CR5","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1212\/WNL.58.5.758","volume":"58","author":"MH Tabert","year":"2002","unstructured":"Tabert MH, Albert SM, Borukhova-Milov L, Camacho Y, Pelton G, Liu X, Stern Y, Devanand DP. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology. 2002;58:758\u201364.","journal-title":"Neurology"},{"issue":"5","key":"471_CR6","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1017\/S003329171000142X","volume":"41","author":"T Luck","year":"2011","unstructured":"Luck T, et al. Impact of impairment in instrumental activities of daily living and mild cognitive impairment on time to incident dementia: results of the Leipzig Longitudinal Study of the Aged. Psychol Med. 2011;41(5):1087\u201397.","journal-title":"Psychol Med"},{"issue":"1","key":"471_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3233\/JAD-131796","volume":"42","author":"K Roy","year":"2014","unstructured":"Roy K, et al. Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer\u2019s disease spectrum. J Alzheimers Dis. 2014;42(1):291\u2013300.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"471_CR8","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","volume":"32","author":"SM Landau","year":"2011","unstructured":"Landau SM, et al. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging. 2011;32(7):1207\u201318.","journal-title":"Neurobiol Aging"},{"key":"471_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00415-005-0551-3","volume":"252","author":"E Salmon","year":"2005","unstructured":"Salmon E, et al. Cerebral metabolic correlates of four dementia scales in Alzheimer\u2019s disease. J Neurol. 2005;252:283\u201390.","journal-title":"J Neurol"},{"issue":"6","key":"471_CR10","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1001\/archneurol.2010.118","volume":"67","author":"OC Okonkwo","year":"2010","unstructured":"Okonkwo OC, et al. Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease. Arch Neurol. 2010;67(6):688\u201396.","journal-title":"Arch Neurol"},{"issue":"3","key":"471_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3233\/JAD-132768","volume":"41","author":"GA Marshall","year":"2014","unstructured":"Marshall GA, et al. Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer\u2019s disease spectrum. J Alzheimers Dis. 2014;41(3):719\u201328.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"471_CR12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3233\/JAD-2010-1245","volume":"19","author":"ED Vidoni","year":"2010","unstructured":"Vidoni ED, Honea RA, Burns JM. Neural correlates of impaired functional independence in early Alzheimer\u2019s disease. J Alzheimers Dis. 2010;19(2):517\u201327.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"471_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neurobiolaging.2010.02.001","volume":"33","author":"NK Nadkarni","year":"2012","unstructured":"Nadkarni NK, Levy-Cooperman N, Black SE. Functional correlates of instrumental activities of daily living in mild Alzheimer\u2019s disease. Neurobiol Aging. 2012;33(1):53\u201360.","journal-title":"Neurobiol Aging"},{"issue":"11","key":"471_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s11910-014-0500-6","volume":"14","author":"N Okamura","year":"2014","unstructured":"Okamura N, et al. Tau PET imaging in Alzheimer\u2019s disease. Curr Neurol Neurosci Rep. 2014;14(11):500.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"19","key":"471_CR15","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1523\/JNEUROSCI.0485-18.2018","volume":"38","author":"SL Leal","year":"2018","unstructured":"Leal SL, et al. Subthreshold amyloid predicts tau deposition in aging. J Neurosci. 2018;38(19):4482\u20139.","journal-title":"J Neurosci"},{"issue":"1","key":"471_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson KA, et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016;79(1):110\u20139.","journal-title":"Ann Neurol"},{"key":"471_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2018.01.024","volume":"66","author":"SR Das","year":"2018","unstructured":"Das SR, et al. Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake. Neurobiol Aging. 2018;66:49\u201358.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"471_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JAD-170945","volume":"62","author":"L Xie","year":"2018","unstructured":"Xie L, et al. Early tau burden correlates with higher rate of atrophy in transentorhinal cortex. J Alzheimers Dis. 2018;62(1):85\u201392.","journal-title":"J Alzheimers Dis"},{"key":"471_CR19","doi-asserted-by":"publisher","unstructured":"Adams JN, et al. Relationships between tau and glucose metabolism reflect Alzheimer\u2019s disease pathology in cognitively normal older adults [Published online ahead of print, April 18, 2018]. Cereb Cortex. \n                    https:\/\/doi.org\/10.1093\/cercor\/bhy078\n                    \n                  .","DOI":"10.1093\/cercor\/bhy078"},{"key":"471_CR20","doi-asserted-by":"crossref","unstructured":"Whitwell JL, et al. Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(8):1005-14.","DOI":"10.1016\/j.jalz.2018.02.020"},{"issue":"6","key":"471_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1590\/S1807-59322011000600021","volume":"66","author":"LdG Vasconcelos","year":"2011","unstructured":"Vasconcelos LdG, et al. Voxel-based morphometry findings in Alzheimer\u2019s disease: neuropsychiatric symptoms and disability correlations - preliminary results. Clinics. 2011;66(6):1045\u201350.","journal-title":"Clinics"},{"key":"471_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"471_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0010-9452(78)80049-5","volume":"14","author":"HE Nelson","year":"1978","unstructured":"Nelson HE, O\u2019Connell A. Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex. 1978;14(2):234\u201344.","journal-title":"Cortex"},{"key":"471_CR24","unstructured":"Rey A. L'examen clinique en psychologie. Paris: Presses Universitaires de France; 1964."},{"issue":"5","key":"471_CR25","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1093\/brain\/awx046","volume":"140","author":"D Tosun","year":"2017","unstructured":"Tosun D, et al. Association between tau deposition and antecedent amyloid-beta accumulation rates in normal and early symptomatic individuals. Brain. 2017;140(5):1499\u2013512.","journal-title":"Brain"},{"issue":"3","key":"471_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-170001","volume":"59","author":"JR Gatchel","year":"2017","unstructured":"Gatchel JR, et al. Depressive symptoms and tau accumulation in the inferior temporal lobe and entorhinal cortex in cognitively normal older adults: a pilot study. J Alzheimers Dis. 2017;59(3):975\u201385.","journal-title":"J Alzheimers Dis"},{"key":"471_CR27","doi-asserted-by":"crossref","unstructured":"Jutten RJ, Dicks E, Vermaat L, Barkhof F, Scheltens P, Tijms BM, Sikkes SAM. Impairment in complex activities of daily living is related to neurodegeneration in Alzheimer\u2019s disease specific regions. Neurobiol Aging. 2018;75:109-16.","DOI":"10.1016\/j.neurobiolaging.2018.11.018"},{"issue":"7","key":"471_CR28","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/ejn.12504","volume":"39","author":"D Liao","year":"2014","unstructured":"Liao D, Miller EC, Teravskis PJ. Tau acts as a mediator for Alzheimer\u2019s disease-related synaptic deficits. Eur J Neurosci. 2014;39(7):1202\u201313.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"471_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2014.09.007","volume":"36","author":"J Bright","year":"2015","unstructured":"Bright J, et al. Human secreted tau increases amyloid-beta production. Neurobiol Aging. 2015;36(2):693\u2013709.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"471_CR30","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jalz.2014.11.001","volume":"11","author":"MW Weiner","year":"2015","unstructured":"Weiner MW, et al. 2014 update of the Alzheimer\u2019s Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement. 2015;11(6):e1\u2013120.","journal-title":"Alzheimers Dement"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0471-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-019-0471-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-019-0471-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:34:58Z","timestamp":1589542498000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-019-0471-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["471"],"URL":"https:\/\/doi.org\/10.1186\/s13195-019-0471-6","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"assertion":[{"value":"17 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Partners Healthcare Institutional Review Board (IRB) approved the study, as did the IRB of each Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) site. Written informed consent was obtained from all participants prior to initiation of any study procedures in accordance with IRB guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have received research salary support from Eisai Inc. (GAM), Eli Lilly and Company (GAM, KAJ, RAS), Janssen Alzheimer Immunotherapy (DMR, GAM, KAJ, RAS), Avid Radiopharmaceuticals (KAJ, RAS), Navidea (KAJ), and Pfizer (KAJ). Additionally, DMR has served as a consultant for Eli Lilly, Neurotrack, Biogen, and Lundbeck Pharmaceuticals; GAM has served as a consultant for Grifols Shared Services North America, Inc. and Pifzer; KAJ has served as a consultant for Bayer, GE Healthcare, Janssen Alzheimer\u2019s Immunotherapy, Siemens Medical Solutions, Genzyme, Novartis, Biogen, Roche, ISIS Pharma, AZTherapy, GEHC, Lundberg, and Abbvie; and RAS has served as a consultant for AbbVie, Biogen, Bracket, Genentech, Lundbeck, Roche, and Sanofi.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"14"}}